Recent Finacing
Recent Raise
Navinci Diagnostics develops and markets in situ proximity ligation assays to detect proteins, PD‑1/PD‑L1 interactions, and post‑translational modifications in tissue and cell samples for immuno‑oncology research and drug development.
